2009). Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields. Fig. 1. FAAH inhibitors OL-135 and URB597 and lead compounds of this study (1a-c).
a r t i c l e i n f o a b s t r a c t
Fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) are the main enzymes responsible for the hydrolysis of endogenous cannabinoids N-arachidonoylethanolamide (AEA) and 2-arachidonoylglycerol (2-AG), respectively. Phenyl alkylcarbamates are FAAH inhibitors with anxiolytic and analgesic activities in vivo. Herein we present for the first time the synthesis and biological evaluation of a series of chiral 3-(2-oxazoline)-phenyl N-alkylcarbamates as FAAH inhibitors. Furthermore, the structural background of chirality on the FAAH inhibition is explored by analyzing the protein-ligand interactions. Remarkably, 10-fold difference in potency was observed for (R)-and (S)-derivatives of 3-(5methyl-4,5-dihydrooxazol-2-yl)phenyl cyclohexylcarbamate (6a vs. 6b). Molecular modelling indicated an important interaction between the oxazoline nitrogen and FAAH active site.
Ó 2009 Elsevier Masson SAS. All rights reserved.
Introduction
The endocannabinoid system contains two major endogenous agonists, N-arachidonoylethanolamide (AEA) [1] and 2-arachidonoylglycerol (2-AG) [2, 3] . These compounds, also called endocannabinoids, activate cannabinoid receptors CB1 and CB2. Activation of these receptors has been reported to induce several biological effects [4, 5] such as relief of pain [6] and anxiety [7] , increase of appetite [8] and reduction of intraocular pressure [9] . Additionally, the activation of CB2 receptors is involved in the dampening of inflammation, lowering of blood pressure, and suppression of peripheral pain [10] . The cannabinoid signaling system is activated by increasing the levels of endocannabinoids upon demand, beginning from biosynthesis of endocannabinoids in postsynaptic neurons, and terminating in degradation of them [11, 12] . The key enzymes responsible for the hydrolysis of endocannabinoids are fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL, EC 3.1.1.23) [13, 14] . FAAH is mainly responsible for hydrolysis of AEA to arachidonic acid and ethanolamine, and MGL for hydrolysis of 2-AG to arachidonic acid and glycerol [15] [16] [17] . Numerous potent inhibitors against FAAH have been reported, including compounds that have shown promising in vivo activity, selectivity and therapeutic effects [18] [19] [20] [21] . Boger et al. introduced a large number of potential inhibitors based on a-ketoheterocycles (e.g. OL-135, Fig. 1 ) that reversibly form hemiketals with the active site serine [22] . N-Alkylcarbamates constitute a second widely explored class of inhibitors, including the well studied compound URB597 (Fig. 1) by Piomelli et al. [7, 23, 24] . Inhibition by N-alkylcarbamates is based on irreversible acylation of the active site serine [25] . Recently reported other structure families with inhibitory activity against FAAH include (thio)hydantoins [26] , piperidine-and piperazine ureas [27, 28] , sulfonyl derivatives [29] and boronic acid derivatives [30] .
To our knowledge, thus far no systematic study on the effect of chirality on the activity of FAAH inhibitors has been presented. The stereoselectivity of FAAH has been explored briefly: while studying AEA derivatives as FAAH substrates, Makriyannis et al. found that within the enantiomeric pairs of certain methanandamides the ones having higher affinity towards CB1 receptor were also less susceptible for FAAH hydrolysis [31] . This information, together with the stereoselectivity of the proteins in general, led us to design and study a series of carbamate enantiomeric pairs as potential FAAH inhibitors.
In the present study, novel N-alkylcarbamates were synthesized based upon compounds 1a-c ( Fig. 1 ) reported in our previous study [32] . Compounds 1a-c inhibit FAAH with IC 50 values of 109, 28 and 47 nM, respectively.
The optimization of the heterocyclic portion of compounds 1a-c was carried out by preparing compounds 2a-3c (Table 1 ). 2-(4,5-Dihydro)-oxazolyl moiety has been widely utilized in ligands of the stereoselective catalysts proving their high chemical stability in various chemical environments [33] . Thus the potential importance of stereochemistry in FAAH inhibition was investigated by preparing chiral 2-oxazoline derivatives of 3c (compounds 4b-7). The enantiopurity of chiral compounds was determined using chiral normal phase HPLC. Compounds 2a-7 (Table 1) were consequently tested for their ability to inhibit both FAAH and MGL. Inhibition of FAAH activity was assayed in rat cerebrum homogenate using [ 3 H]-radiolabelled AEA as a substrate. Enzyme inhibition studies for MGL were conducted in rat cerebellar membranes using 2-AG as a substrate. The formation of arachidonic acid, the hydrolysis product of 2-AG, was measured by reversed-phase HPLC. Compounds 2c, 6a and 6b were tested for inhibition of human recombinant MGL (Cayman Chemical) catalyzed hydrolysis of [ 3 H]labelled 2-oleoylglycerol. The results of the in vitro experiments are summarized in Table 1 . In addition, to understand the structural background of chirality on the FAAH inhibition, the enantiomeric pairs were docked to the FAAH active site, and the protein-ligand interactions were further analyzed with the aid of molecular interaction fields (MIFs).
Chemistry
The synthesis of compounds 2a-c is presented in Scheme 1. Aminophenol 8a, 2-amino-3-hydroxypyridine 8b and 2-amino-3hydroxypyrimidine 14 were condensed with 3-hydroxybenzoic acid [34] . Compound 14 was prepared in four steps from methyl methoxyacetate 10 [35, 36] . Phenols 9a-b and 15 were carbamoylated by refluxing them with isocyanates and triethylamine in toluene.
Scheme 2 illustrates the synthesis of compounds 3a-7. 3-(2-Oxazoline)-phenol 16 was prepared via the method described by Vorbrü ggen et al. [37] . Compound 17 was prepared by condensing 3-cyanophenol with 2-amino-2-methylpropanol using bismuth triflate catalysis under microwave irradiation [38] . Unfortunately this method gave poor yields. Thus for the preparation of intermediates 18a-e, the method by Witte and Seeliger [39] , was applied. Compounds 19a-d were prepared in high yields via acidic Pinner imidates [40] . Carbamates were then prepared as 2a-c.
Results and discussion
We first studied the importance of ketone group between benzoxazole and 3-carbamoyl-phenyl in compound 1a. The results of the in vitro inhibition studies showed that the absence of a ketone group within these fused bicyclic aromatic compound (e.g. 1a vs. 2a) decreases the FAAH-inhibition activity. Introducing a nitrogen atom into the fused oxazole-containing bicycle (2b) increased the inhibitory activity compared to compound 2a. Addition of a second nitrogen did not enhance the activity: oxazolo [4,5-d] pyrimidin-2-yl-containing 2c was clearly less active than 2b. Additionally compound 3a, which only contained the unsubstituted 2-oxazoline ring, showed good inhibitory activity against FAAH with an IC 50 value of 33 nM. We found earlier [32] that the cyclopentyl derivative 1b (IC 50 ¼ 28 nM) was more active than the npropyl derivative 1a (IC 50 ¼ 109 nM). Similar enhancement in activity was observed for compound 3b in comparison to 3a. Later it was discovered that changing the carbamate N-alkyl group from cyclopentyl to cyclohexyl gave a further increase in activity (3b vs. 3c, 4a vs. 4b and 4c vs. 5a), and hence cyclohexyl was used as the N-alkyl group for the rest of the series.
Furthermore, substitution in the 4-position of the oxazoline ring was found to decrease FAAH inhibition. Compound 4a (4-dimethyl) was 5-fold and compound 4c ((S)-4-Me) 10-fold less active than 3b. A tentative presumption was made: if 4a containing two methyl substituents at C4 has a better activity than 4b, which only has the (S)-methyl, then a compound with the (R)-methyl at C4 should be more active against FAAH than either of these. Indeed, a clear relationship between the activity against FAAH and stereochemistry of the 4-position of oxazoline was revealed by the data of compounds 5a-f. With methyl (5a vs. 5b) and benzyl (5c vs. 5d) substituents, the difference in activity between enantiomers was only 3-fold, but with methyl carboxylate (5e vs. 5f) already 10-fold. This could be explained by the methyl ester's additional hydrogen bonding site or by the optimal size of the substituent. The lower activity of benzyl substituent analogs in general indicates that the enantiomeric differences in potency arise from steric hindrance. It might be that interactions between FAAH and benzyl lead to a suboptimal positioning of the carbamate functionality in the vicinity of the catalytic serine. In addition, the effect of a substituent in 5-position of oxazoline was studied with 5-methyl analogs 6a and b. Compound 6b was found to inhibit FAAH with equal potency with the most potent compound (5f) in the series of 4-substituted Table 1 Structures and in vitro activity of the synthesized compounds. oxazolines. Furthermore, when a bulky S-indolyl group (7) was introduced at 4-position of oxazoline a significant decrease in the FAAH-inhibition activity was observed. None of the tested compounds showed significant activity against MGL at 100 mM compound concentration, and therefore IC 50 values were not determined. As we found in our earlier work, in phenyl carbamates inhibiting MGL, para-substitution is more favorable than metasubstitution [32] . The stereochemistry of the compounds is illustrated in Fig. 2 . In these Newman projections, the more active compounds 5f and 6b are the ones with their chiral carbon substituent ''up'' from the plane of the ring. This trend was also present in the enantiomeric pairs 5a vs. 5b and 5c vs. 5d. These examples suggest that the stereochemistry in the oxazoline is more important than the regiochemistry of substitution (C4 or C5). This implies that the oxazoline ring conformation is locked within the enzyme's active site. This would explain the activity difference between the enantiomeric pairs since the substituent of the chiral carbon is pointing to a specific direction and thus filling the possible hydrophobic pocket or conversely causing steric hindrance.
Molecular modelling was performed to investigate the differences in the inhibitory activities of the enantiomeric pairs. In particular, in this approach, we focused on exploring the differences arising from the protein-ligand interactions of the recognition process, as it can be assumed that the reactivity of the compounds is in similar level within the enantiomeric pairs. It should be noted that a crystal structure of partially humanized rat FAAH with a druglike inhibitor PF-750 [41] (PDB code 2VYA) has been published recently. This structure shows structural rearrangements in the substrate access channel region with Phe432 flipping into the acyl chain binding (ACB) channel. However, owing to our FAAH in vitro assay in rat brain homogenate, we docked the compounds to the crystal structure of murine FAAH (PDB code 1MT5) [42] with GOLD [43], and the top-ranking pose of the most abundant cluster was visualized for each enantiomer (see Experimental section for details). There is a speculation of a general FAAH binding mode of Nalkylcarbamates before the acylation (carbamoylation) reaction occurs [24, 44, 45] . In our docking study, the binding of all the enantiomers was indeed in agreement with this mode, and the ligands were positioned in a conformation where the N-cyclohexyl moiety is pointing towards the branching point of the ACB and substrate access channels, and forming van der Waals interactions with Phe194, Phe244, and Ile491. The oxygen of the carbamate carbonyl is accepting hydrogen bond(s) from the backbone N-H groups of the FAAH oxyanion hole residues (Ile238-Ser241) [42] , thus giving rise to a conformation where the electropositive acarbon of the ligand is residing next to the nucleophilic hydroxyl of catalytic Ser241. Moreover, the O-aryl part is pointing towards the cytoplasmic access (CA) cavity leading to the intracellular surface of FAAH. Noticeably, a common feature between all the enantiomeric pairs was that in enantiomers with ''up''-substitutions, the oxazoline oxygen atom is pointing roughly towards the side chain of Leu192, whereas in the ''down''-substituted enantiomers the oxazoline ring is flipped approximately 180 . This is most probably due to the shape of the CA cavity, and the backbone of Ser190 and the side chain of Cys269 in particular, which are sterically locking the ring in either of the aforementioned conformations. Also, it should be noted that the methyl ester of 5f is capable of accepting a hydrogen bond from the backbone of Val270 in contrast to 5e where no such interaction is observable ( Fig. 3) .
In order to further emphasize the probable interaction points in the FAAH binding site, we applied molecular interaction field (MIF) analysis by GRID [46] with probes corresponding the oxazoline ring and its substituents of the studied enantiomers. In this method, the protein active site is enclosed in a grid cage, and the interaction energies between amino acid residues and probes are calculated. The resulting MIFs can be then used to determine the most favorable interaction regions in the active site. By visualizing the MIFs in the light of the docked compounds, no explanation for the inhibition activity differences arising from the oxazoline ring substituent conformations could be seen, apart from the carbonyl oxygen probe indicating a favorable interaction with Val270 backbone (corresponding to the aforementioned hydrogen bond of the methyl ester of 5f). However, when studying the MIFs in the binding region of the oxazoline ring, the sp 2 nitrogen probe showed strong interaction with the backbone of Cys269 and Val270 (Fig. 4a ). Furthermore, with the same interaction energy level, no interaction is observed with these residues and aromatic/aliphatic ether oxygen probe (Fig. 4b ). This is in line with the docking results, and suggests that the ''up''substituted carbamates are forming an electrostatic interaction between the oxazoline ring nitrogen and the backbone N-H groups of Cys269 and Val270, whereas in ''down''-substituted compounds the interaction between the ring oxygen and these residues is clearly less favorable. This type of interaction between oxazoline nitrogen and protein backbone is not uncommon, and in Relibase [47] one can find cases of similar drug-receptor interactions (e.g. [48] ).
To gain confidence in this observation, we wanted to assess the electronic properties of the enantiomers in more detail by calculating the electrostatic potentials V(r)s with an ab initio method. In all of the optimized structures the minima of the electrostatic potential was located in the vicinity of the oxazoline nitrogen ( Fig. 5 ). This indirectly indicates the oxazoline nitrogen having higher interaction potential compared to the oxygen [49, 50] . Thus, it seems the IC 50 differences of the enantiomeric pairs might be indeed due to the sterical features of the FAAH active site, and the consequential electrostatic dipole-dipole interaction of the ''up''substituted oxazoline carbamates with the Cys269 and Val270 backbone N-H groups.
Conclusion
In conclusion, a series of chiral 3-oxazolinylphenyl N-alkylcarbamates were prepared and tested for their in vitro inhibitory activity against FAAH and MGL. In this series, enantiomers having their chiral center substituent ''up'' from plane of the oxazoline ring (5b, 5d, 5f, 6b) were found to be more potent FAAH inhibitors than corresponding ''down'' enantiomers. The most potent chiral compound, (R)-3-(5-methyl-4,5-dihydrooxazol-2-yl)phenyl cyclohexylcarbamate (6b), inhibited FAAH with approximately 10-fold higher potency (IC 50 value: 6.8 nM) than the corresponding (S)enantiomer (6a, IC 50 value: 73 nM). In addition, non-substituted oxazoline derivative (3b, IC 50 value: nM) was found to be more potent than any of the corresponding substituted compounds. None of the compounds presented significantly inhibited MGL activity. Since the carbamate based FAAH inhibitors have been reported to have several off-targets [19, 25, 51] the selectivity of chiral 3-oxazolinylphenyl N-alkylcarbamates would be important issue to study in more detail in the future. In molecular modelling studies, the combined docking and molecular interaction field analysis emphasized the importance of heterocycle interaction with Cys269 and Val270 of FAAH, and also highlighted the steric features of the FAAH active site. These findings could provide [4,5-b] pyridin-2-yl)phenol (9b) [34, 54] 3-Hydroxybenzoic acid (250 mg, 1.8 mmol, 150 mol-%) and 2amino-3-hydroxypyridine (8b, 130 mg, 1.2 mmol, 100 mol-%) were microwave-irradiated (300 W, 4 min ramp to 250 C, hold 2 min). The tan solid was dissolved to MeOH/EtOAc (1:1, 10 mL), poured to sat. aq. NaHCO 3 (30 mL) and extracted with EtOAc (3 Â 50 mL). Combined organic phases were washed with water (50 mL) and brine (50 mL 
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5-Methoxypyrimidin-4(3H)-one (11) [55]
Methyl 2-methoxyacetate (10, 10.4 g, 100 mmol, 100 mol-%) and methyl formate (7.2 g, 120 mmol, 120 mol-%) were added to a mixture of sodium hydride (5.6 g of 60% dispersion in oil, 140 mmol, 140 mol-%) in dry THF (150 mL) and stirred for 20 h keeping the temperature of the mixture at 20 C by water bath. After formation of white solid, dry Et 2 O (100 mL) was added and the mixture was filtered. The solid (18.6 g) was dried under reduced pressure and added to a mixture of formamidine acetate (10.4 g, 100 mmol, 100 mol-%) in EtOH (200 mL) at rt. The mixture was stirred for 14 h at rt and refluxed for 24 h. Water (70 mL) was added and the mixture was acidified with AcOH (25 mL) from pH 10 to 5. Ethanol was evaporated and the residue was extracted with CHCl 3 (10 Â 100 mL) and EtOAc:Et 2 O (2:1, 3 Â 100 mL). Combined organic phases were dried over MgSO 4 , filtered and evaporated. Crystallization of the crude product (MeOH:hex) gave 11 (3.9 g, 31%) as off-white solid: mp. 216-217 C; R f (10% MeOH in CH 2 Cl 2 ) 0.2; 1 H NMR (DMSO-d 6 ) 12.51 (br s, 1H), 7.81 (s, 1H), 7.52 (s, 1H), 3.73 (s, 3H).
4-Chloro-5-methoxypyrimidine (12) [53]
Compound 11 (2.6 g, 20.6 mmol, 100 mol-%) was treated with phosphorus oxychloride (17 mL, 180 mmol, 900 mol-%) at 0 C. The mixture was refluxed for 2.5 h, cooled to 30-40 C and unreacted POCl 3 was removed under reduced pressure. Ice-cold water (50 mL) was added and pH was adjusted to 7 with K 2 CO 3 (10 g). 
5-Methoxypyrimidin-4-amine (13) [56]
The mixture of 12 (3.4 g, 24 mmol, 100 mol-%) in EtOH (30 mL) was bubbled with dry NH 3 gas for 30 min at 0 C. The mixture was poured to autoclave and stirred at 130 C for 18 h. Cooling and evaporation resulted in tan residue which was dissolved to CHCl 3 (100 mL) and brine (100 mL) and extracted with CHCl 3 (3 Â 100 mL). Combined organic phases were dried over MgSO 4 , filtered and evaporated giving 13 (2.2 g, 75%) as a yellow solid; mp. 117-119 C; R f (10% MeOH in CH 2 Cl 2 ) 0.4; 1 H NMR (DMSO-d 6 ) 7.99 (s, 1H,), 7.79 (s, 1H), 6.68 (s, 2H), 3.80 (s, 3H).
4-Aminopyrimidin-5-ol (14) [57]
The mixture of 13 (280 mg, 2.2 mmol, 100 mol-%) in dry DMF (15 mL) was treated with NaH (215 mg, washed with hexanes from 60% mineral oil dispersion, 9.0 mmol, 400 mol-%) at rt. The mixture was cooled by ice bath and n-BuSH (300 mg, 3.3 mmol, 150 mol-%) was added. The mixture was stirred at 110 C for 20 h and evaporated to dryness. AcOH (0.25 mL) and water (2.5 mL) were added and evaporation was repeated. 
Biological testing protocols
Animals and preparation of rat brain homogenate for FAAH assay
Eight-week-old male Wistar rats were used in these studies. All animal experiments were approved by the local ethics committee. The animals lived in a 12-h light/12-h dark cycle (lights on at 0700 h) with water and food available ad libitum.
The rats were decapitated, whole brains minus cerebellum were dissected and homogenized in one volume (v/w) of ice-cold 0.1 M potassium phosphate buffer (pH 7.4) with a Potter-Elvehjem homogenizer (Heidolph). The homogenate was centrifuged at 10,000g for 20 min at 4 C and the resulting supernatant was used as a source of FAAH activity. The protein concentration of the supernatant (7.2 mg/mL) was determined by the method of Bradford with BSA as the standard [59] . Aliquots of the supernatant were stored at À80 C until use.
Animals and preparation of rat cerebellar membranes for MGL assay
Four-week-old male Wistar rats were used in these studies. All animal experiments were approved by the local ethics committee. The animals lived in a 12-h light/12-h dark cycle (lights on at 0700 h), with water and food available ad libitum. The rats were decapitated, 8 h after lights on (1500 h), whole brains were removed, dipped in isopentane on dry ice and stored at À80 C. Membranes were prepared as previously described [60] [61] [62] .
Briefly, cerebella (minus brain stem) from eight animals were weighed and homogenized in nine volumes of ice-cold 0.32 M sucrose with a glass Teflon homogenizer. The crude homogenate was centrifuged at low speed (1000g for 10 min at 4 C) and the pellet was discharged. The supernatant was centrifuged at high speed (100,000g for 10 min at 4 C). The pellet was resuspended in ice-cold deionized water and washed twice, repeating the highspeed centrifugation. Finally, membranes were resuspended in 50 mM Tris-HCl, pH 7.4 with 1 mM EDTA and aliquoted for storage at À80 C. The protein concentration of the final preparation, measured by the Bradford method [59] , was 11 mg/mL.
In vitro assay for FAAH activity
The assay for FAAH activity has been described previously [63] . The endpoint enzymatic assay was developed to quantify FAAH activity with tritium-labelled arachidonoylethanolamide (ethanolamine 1-3 H). The assay buffer used was 0.1 M potassium phosphate (pH 7.4) and test compounds were dissolved in DMSO (the final DMSO concentration was max 5% v/v). The incubations were performed in the presence of 0.5% (w/v) BSA (essentially fatty acid free). Test compounds were preincubated with rat brain homogenate protein (18 mg) for 10 min at 37 C (60 mL). At the 10 min time point, arachidonoylethanolamide was added so that its final concentration was 2 mM (containing 50 Â 10 À3 mCi of 60 Ci/mmol [ 3 H]AEA) and the final incubation volume was 100 mL. The incubations proceeded for 10 min at 37 C. EtOAc (400 mL) was added at the 20 min time point to stop the enzymatic reaction. Additionally, 100 mL of unlabelled ethanolamine (1 mM) was added as a 'carrier' for radioactive ethanolamine. Samples were centrifuged at 16,000g for 4 min at rt, and aliquots (100 mL) from aqueous phase containing [ethanolamine 1-3 H] were measured for radioactivity by liquid scintillation counting (Wallac 1450 MicroBeta; Wallac Oy, Finland).
In vitro assay for MGL activity in rat cerebellar membranes
The assay for MGL activity has been described previously [64] .
Briefly, experiments were carried out with preincubations (80 mL, Samples were centrifuged at 23,700g for 4 min at rt prior to HPLC analysis of the supernatant.
HPLC method
The analytical HPLC was performed as previously described [17] . Briefly, the analytical HPLC system consisted of a Merck Hitachi (Hitachi Ltd., Tokyo, Japan) L-7100 pump, D-7000 interface module, L-7455 diode-array UV detector (190-800 nm, set at 211 nm) and L-7250 programmable autosampler. The separations were accomplished on a Zorbax SB-C18 endcapped reversed-phase precolumn (4.6 Â 12.5 mm, 5 mm) and column (4.6 Â 150 mm, 5 mm) (Agilent, USA). The injection volume was 50 mL. A mobile phase mixture of 28% phosphate buffer (30 mM, pH 3.0) in acetonitrile was used at a flow rate of 2.0 mL/min. Retention times were 5.8 min for 2-AG, 6.3 min for 1(3)-AG and 10.2 min for arachidonic acid. The relative concentrations of 2-AG, 1(3)-AG and arachidonic acid were determined by the corresponding peak areas. This was justified by the equivalence of response factors for the studied compounds, and was supported by the observation that the sum of the peak areas was constant throughout the experiments.
Human recombinant MGL assay
The endpoint enzymatic assay was developed to quantify human recombinant MGL (Cayman Chemical, cat# 10008354) activity with tritium-labelled 2-oleoylglycerol (2-OG) [glycerol-1,2,3-3 H] (American Radiolabeled Chemicals Inc., St Louis, MO, USA). The assay buffer was 50 mM Tris-HCl, pH 7.4; 1 mM EDTA and test compounds were dissolved in DMSO (the final DMSO concentration was not more than 5% v/v). The incubations were performed in the presence of 0.5% (w/v) BSA (essentially fatty acid free). hrMGL was preincubated with test compounds for 10 min at 37 C (60 mL). At The samples were centrifuged at 16,000g for 4 min at rt, and aliquots (100 mL) were taken from the aqueous phase, which contained glycerol-1,2,3-3 H, and measured for radioactivity by liquid scintillation counting (Wallac 1450 MicroBeta; Wallac Oy, Finland).
Data analyses
The results from the enzyme inhibition experiments are presented as mean AE 95% confidence intervals of at least three independent experiments performed in duplicate. Data analyses for the dose-response curves were calculated as non-linear regressions using GraphPad Prism 4.0 for Windows.
Molecular modelling
Structure construction
The 3-D coordinates in the X-ray crystal structure of murine FAAH in complex with covalently bound inhibitor methyl arachidonyl fluorophosphonate (MAFP) (Protein Data Bank code 1MT5, resolution 2.8 Å) [42] was used as an enzyme model for the docking calculations. Missing side chain atoms were added into the FAAH monomer (chain A extracted from the X-ray data) of the crystal structure by using Lovell rotamer library [65] and optimized in polarizable AMBER07_FF02 force field [66] (energy gradient of 0.01 kcal/mol) while keeping the rest of the protein atoms fixed, as implemented in Sybyl 8.1 [67] . Hydrogen atoms were added with MolProbity (v. 3.15) [68] server by allowing the program to optimize hydrogen bonding by flipping Asn, Gln or His, where applicable. The orientation of the hydrogen atoms of the catalytic region amino acids (catalytic triad) [42, 69] was inspected to ensure that a hydrogen bond was formed between hydroxyl groups of Ser217 and Ser241 and one between side chain of Ser217 and side chain of Lys142.
The 3-D coordinates of the ligands were generated in Sybyl 8.1 following an energy minimization to energy gradient of 0.005 kcal/ mol in Merck molecular force field (MMFF94s) [70] with Powell conjugate gradient method.
Molecular docking
Version 4.0 of GOLD [43] was used as a docking tool in this study. The binding site of FAAH was defined to range 15 Å radius from the oxygen atom of catalytic Ser241 side chain hydroxyl group (with 'detect cavity' feature of GOLD toggled on). The default GoldScore empirical fitness function was used as a scoring function for the generated poses. In order to maximize the conformational space sampled during the docking calculations, a preset '200% efficiency' setting was utilized for 1000 separate genetic algorithm (GA) docking runs for each ligand. To ensure that different possible binding modes are inspected upon visualization of the results, and not only the top-ranking poses, RMSD-based complete linkage clustering was applied. Clustering distance of 1.0 Å (as implemented in GOLD) was used to derive the clusters of poses. The topranking (according to GOLD) poses of three most abundant clusters, in terms of cluster members, were visualized for each ligand. The highest scoring pose of the most abundant cluster was considered for the further analyses.
GRID interaction fields
In order to analyze and identify possible hot spots for favorable protein-ligand interactions in the FAAH active site and consequently shed light on the measured enantiopreference, GRID [46] molecular interaction field (MIF) analysis was carried out. For GRID calculations, the active site of the modified FAAH structure (see Section 5.3.1) was enclosed in a 26 Â 26 Â 25 Å box with grid spacing of 0.2 Å. Only lone pairs and tautomeric hydrogens were allowed to alter in response to the probes (directive MOVE ¼ 0). To reflect the oxazoline ring and its different substituents found in the enantiomeric pairs, the following GRID probes were used in this study: methyl (C3), sp 2 aromatic carbon (C1]), sp 2 nitrogen with a lone pair (N:]), sp 2 carbonyl oxygen (O), and aromatic/aliphatic ether oxygen (OC1). The resulting MIFs were visually analyzed.
Electrostatic potential
To briefly explore the nucleophilic characteristics of the chiral carbamates, we calculated the electrostatic potential V(r) of the enantiomers. Starting from the docked conformations, the molecules were optimized and V(r) was calculated in Hartree-Fock/6-311G ** level of theory with Gaussian 03 [71] . The V(r) isosurfaces were visualized with VMD 1.8.6 [72] . 
